SCHEMBL13829409

SCHEMBL13829409

COc1ccc(C2Oc3ccccc3C(=O)C2Sc2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.51
CYP19A1 P11511 5/20 0.51
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
MAOB P27338 1/20 0.51
HPGD P15428 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
TP53 P04637 1/20 0.48
MAOA P21397 1/20 0.48
PTGS2 P35354 1/20 0.48
NPSR1 Q6W5P4 1/20 0.46
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
RET P07949 1/20 0.42
KDR P35968 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
MEN1 O00255 2/20 0.42
POLB P06746 2/20 0.42
HTT P42858 2/20 0.42
KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13719183 0.86 RET (0.47) MAPTCYP19A1NPC1RAB9AMAOB
SCHEMBL4224331 0.78 MAPT (0.52) MAPTCYP19A1NPC1RAB9AMAOB
SCHEMBL11256026 0.74 MAPT (0.51) MAPTCYP19A1NPC1RAB9AMAOB
SCHEMBL14895951 0.71 MAPT (0.63) MAPTCYP19A1NPC1RAB9AMAOB
SCHEMBL1893757 0.71 MAPT (0.50) MAPTCYP19A1NPC1RAB9AMAOB
SCHEMBL29209376 0.71 MAPT (0.47) MAPTCYP19A1NPC1RAB9AMAOB
SCHEMBL1893755 0.71 MAPT (0.50) MAPTCYP19A1NPC1RAB9AMAOB
SCHEMBL30638795 0.70 CYP19A1 (0.57) CYP19A1MAOBSMN1; SMN2ABCB1AR
SCHEMBL29397268 0.70 CYP19A1 (0.57) CYP19A1MAOBSMN1; SMN2ABCB1AR
SCHEMBL17637164 0.70 KDM4E (0.58) MAPTCYP19A1NPC1RAB9AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296717-B2 Synthesis of C-3 coupled biflavonoids and C-3 coupled biflavonoid analogues UNIVERSITY OF THE FREE STATE (ZA) 2016-03-29 US disclosed
US-9296717-B2 Synthesis of C-3 coupled biflavonoids and C-3 coupled biflavonoid analogues UNIVERSITY OF THE FREE STATE (ZA) 2016-03-29 US disclosed
US-20120289715-A1 Synthesis of C-3 Coupled Biflavonoids and C-3 Coupled Biflavonoid Analogues UNIVERSITY OF THE FREE STATE (ZA) 2012-11-15 US disclosed
US-20120289715-A1 Synthesis of C-3 Coupled Biflavonoids and C-3 Coupled Biflavonoid Analogues UNIVERSITY OF THE FREE STATE (ZA) 2012-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289715-A1 Synthesis of C-3 Coupled Biflavonoids and C-3 Coupled Biflavonoid Analogues CBR3, C9, PROC MAPT 4751/4885CYP19A1 481/4885NPC1 2881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.